FDX
34
7
AVB
54
4
NWS
47
2
MSFT
48
-3
ADM
30
2
ICE
55
2
LEN
61
2
DHR
47
-3
UNM
74
2
ETR
63
3
WEC
51
6
BLK
75
2
JBHT
63
7
ESS
57
6
K
56
2
GM
71
5
EMN
56
-4
O
50
2
C
58
5
MS
80
6
FDX
34
7
AVB
54
4
NWS
47
2
MSFT
48
-3
ADM
30
2
ICE
55
2
LEN
61
2
DHR
47
-3
UNM
74
2
ETR
63
3
WEC
51
6
BLK
75
2
JBHT
63
7
ESS
57
6
K
56
2
GM
71
5
EMN
56
-4
O
50
2
C
58
5
MS
80
6
Financhill
Back

Apellis Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
27.90
Seasonality Move:
25.98%
Sell
40

ALNY
Alnylam Pharmaceuticals

Last Price:
296.71
Seasonality Move:
11.91%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.95. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $300.55. The Score for ALNY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $300.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.21 Sell
Relative Strength Index (14 RSI): 34 Sell
Chaikin Money Flow: -61032 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.9 - 34.22) Sell
Bollinger Bands (100): (32.37 - 41.13) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.76 Buy
Relative Strength Index (14 RSI): 75.52 Buy
Chaikin Money Flow: 1043301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (266.78 - 282.26) Buy
Bollinger Bands (100): (196.41 - 285.77) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.35 Buy
20-day SMA: 29.1 Sell
50-day SMA: 34.42 Sell
200-day SMA: 47.21 Sell
8-day EMA: 27.73 Buy
20-day EMA: 29.48 Sell
50-day EMA: 33.11 Sell
200-day EMA: 42.85 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 280.35 Buy
20-day SMA: 275.91 Buy
50-day SMA: 270.69 Buy
200-day SMA: 200.56 Buy
8-day EMA: 283.96 Buy
20-day EMA: 277.03 Buy
50-day EMA: 266.03 Buy
200-day EMA: 219.81 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.30 per share, and an increase next year of $1.30 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $0.76 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):